PharmEasy is India’s largest digital healthcare platform. The company business aims to provide solutions for healthcare needs of consumers across to provide digital tools and information on illness and wellness, teleconsultation, diagnostics and radiology tests, delivering treatment protocols including products and devices.
API Holdings Ltd, PharmEasy’s parent, may also consider a further issue of equity shares via a private placement of up to ₹1250 crore. Some companies like Citigroup Global Markets India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are joint bookrunners in API Holdings’ IPO
According to the DRHP reports, PharmEasy is planning to raise about Rs 6,250 Crores ($842.43 million) through its IPO which is slated to go live in January 2022.
Table of Contents
PharmEasy Company Details
|Founder||Dharmil Sheth, Dr. Dhaval Shah|
|Headquarter||Lal Bahadur Shastri Marg, Mumbai, India|
|Parent organization||91streets Media Technologies Pvt Ltd/API Holdings Pvt Ltd|
PharmEasy IPO Registrar
PharmEasy IPO Details
|IPO Opening Date||TBA|
|IPO Closing Date||TBA|
|Initiation of Refunds||TBA|
|IPO Listing Date||TBA|
|Issue Type||Book Built Issue IPO|
|Min Order Quantity||TBA|
|Listing At||BSE, NSE|
|Offer for Sale||TBA|
PharmEasy IPO Lot Size
|Quantity||Lots||Shares||Amount (in ₹)|
- PharmEasy is valued at $5.6 billion after the company raised an amount of $350 million in two of the most recent rounds of funding, summed up as its Pre-IPO round.
- PharmEasy’s Parent Entity will acquire 100% equity of Medlife and the promoters of Medlife will get a 19.95% stake in the entity.
- PharmEasy has received $1.50 billion in funding to date. PharmEasy had last raised $500 million in the Series F funding round led by Arokiaswamy Velumaniand was valued at $1.8 billion, as of June 2021.
- PharmEasy had acquired 3 companies, ‘Aknamed‘ A healthcare company that strives to streamline the supply chain of the industry in India. ‘Thyrocare technologies‘ it is a full automatic diagnostic laboratory and the third one is ‘Medlife‘ it is an online medicine supplier from Bangalore, India, which has facilities for home delivery.
More information on PharmEasy IPO will be updated soon…
What is PharmEasy?
PharmEasy is a consumer healthcare app that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultations thereby serving their healthcare needs.
What is the share price of PharmEasy?
Share price of PharmEasy will be updated soon.
When is PharmEasy IPO listing date?
PharmEasy IPO listing date will be updated soon.
What is the GMP of PharmEasy IPO?
GMP of PharmEasy IPO will be updated soon.
How much is PharmEasy valuation?
PharmEasy is valued at $5.6 billion after the company raised an amount of $350 million in two of the most recent rounds of funding, summed up as its Pre-IPO round.
Originally posted 2022-01-09 19:56:55.